Logo
x

Search category

Subscribe Now

Injection

Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk Acute Myeloid Leukemia

Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk...

  • July 9, 2021
Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Carcinoma

Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Car...

  • June 29, 2021
Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer

Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer

  • May 27, 2021
Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia

Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia

  • March 24, 2021
B. Braun's Acetaminophen Injection Receives the US FDA Approval in Multiple Doses

B. Braun's Acetaminophen Injection Receives the US FDA Approval in Multiple Doses

  • February 25, 2021
Innovent and Lilly Report Results of Tyvyt (sintilimab) in Seven Clinical Studies to be Presented at the ESMO ASIA Congress 2020

Innovent and Lilly Report Results of Tyvyt (sintilimab) in Seven Clinical Studies to be Presented at the ESMO ASIA Congress 2020

  • November 5, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.